|
Market Closed -
Euronext Paris
09:25:00 20/10/2026 pm IST
|
After hours 01:29:59 am | |||
| 73.58 EUR | +3.62% |
|
73.74 | +0.22% |
| 09:14pm | European Stocks Close Mixed in Tuesday Trading Amid Ongoing Unrest in France, Fighting in Middle East | MT |
| 08:00pm | Sanofi, ScionxBio to Develop Long-Acting xRNA Therapeutics | MT |
| Market Cap | 8.82TCr 9.9TCr 8.17TCr 7.4TCr 14TCr 9,38200Cr 14TCr 98TCr 39TCr 4,91000Cr 37TCr 36TCr 15,66300Cr | P/E 2026 * |
11.7x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 9.95TCr 11TCr 9.22TCr 8.36TCr 16TCr 10,58900Cr 16TCr 1,10600Cr 43TCr 5,54100Cr 42TCr 41TCr 17,67700Cr | EV / Sales 2026 * |
2.09x | EV / Sales 2027 * | 1.9x |
| Free-Float |
88.34% | Yield 2026 * |
5.8% | Yield 2027 * | 6.13% |
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| SAN | Real-time | |
CBOE
| SAN | Real-time | |
Tradegate
| SNW | Real-time | |
Boerse Muenchen
| SNW | Real-time | |
Xetra
| SNW | Delayed | |
Borsa Italiana
| 1SAN | End-of-day quote | |
OTC Markets
| SNYNF | Delayed | |
Deutsche Boerse AG
| SNW | Delayed | |
Börse Stuttgart
| SNW | Delayed | |
London S.E.
| 0O59 | Delayed | |
CBOE
| 0O59 | Real-time | |
Wiener Boerse
| SANO | End-of-day quote | |
Bulgaria S.E.
| SNW | End-of-day quote | |
Swiss Exchange
| SAN | Delayed |
Last Transcript: Sanofi
| 1 day | +3.62% | ||
| 1 week | +2.77% | ||
| Current month | +1.29% | ||
| 1 month | -0.63% | ||
| 3 months | -4.86% | ||
| 6 months | -10.29% | ||
| Current year | -11.05% |
| 1 week | 70.1 | 73.58 | |
| 1 month | 69.75 | 75.3 | |
| Current year | 69.75 | 84.97 | |
| 1 year | 69.75 | 91.15 | |
| 3 years | 69.75 | 110.88 | |
| 5 years | 69.75 | 110.88 | |
| 10 years | 62.88 | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 01/05/2026 | |
| Director of Finance/CFO | 64 | 01/04/2024 | |
Paulo Fontoura
CTO | Chief Tech/Sci/R&D Officer | - | 01/09/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 61 | 30/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 56 | 28/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 28/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/08/26 | Buy | Chief Executive Officer | 1,506 | 0.0001% | ||
| 20/08/26 | Buy | Head of Human Resources | 54 | 0.0000% | ||
| 20/08/26 | Buy | Executive/Senior Manager | 840 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +3.62% | +2.77% | -14.87% | -25.53% | 9.54TCr | ||
| +3.49% | +8.54% | +59.89% | +117.27% | 1,10600Cr | ||
| +2.19% | -1.66% | +34.23% | +70.27% | 61TCr | ||
| +2.26% | +2.83% | +25.92% | +98.65% | 50TCr | ||
| +2.58% | +8.31% | +37.43% | +63.51% | 37TCr | ||
| +3.25% | +1.96% | +74.90% | +47.67% | 35TCr | ||
| +1.85% | +5.45% | +21.38% | +49.26% | 29TCr | ||
| +1.76% | +4.92% | +0.48% | +20.31% | 26TCr | ||
| +3.29% | +5.12% | +46.90% | +56.43% | 23TCr | ||
| +2.25% | +4.04% | +27.44% | +99.53% | 19TCr | ||
| Average | +2.69% | +1.83% | +31.37% | +59.74% | 39.96TCr | |
| Weighted average by Cap. | +2.91% | +2.23% | +40.34% | +77.80% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.76TCr 5.34TCr 4.41TCr 3.99TCr 7.51TCr 5,06200Cr 7.63TCr 53TCr 21TCr 2,64900Cr 20TCr 20TCr 8,45100Cr | 5.07TCr 5.69TCr 4.7TCr 4.26TCr 8TCr 5,39300Cr 8.13TCr 56TCr 22TCr 2,82200Cr 21TCr 21TCr 9,00400Cr |
| Net income | 767.03Cr 861.74Cr 710.88Cr 644.18Cr 1.21TCr 82TCr 1.23TCr 8.53TCr 3.35TCr 43TCr 3.23TCr 3.17TCr 1,36300Cr | 907.32Cr 1.02TCr 840.9Cr 761.99Cr 1.43TCr 97TCr 1.46TCr 10TCr 3.96TCr 51TCr 3.82TCr 3.74TCr 1,61200Cr |
| Net Debt | 1.13TCr 1.27TCr 1.05TCr 952.14Cr 1.79TCr 1,20700Cr 1.82TCr 13TCr 4.95TCr 63TCr 4.78TCr 4.68TCr 2,01400Cr | 800.45Cr 899.28Cr 741.85Cr 672.24Cr 1.26TCr 85TCr 1.28TCr 8.9TCr 3.5TCr 45TCr 3.37TCr 3.3TCr 1,42200Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 20/26/20 | €73.58 | +3.62% | 19,26,589 |
| 19/26/19 | €71.01 | -1.29% | 18,69,514 |
| 16/26/16 | €71.94 | -0.30% | 21,88,087 |
| 15/26/15 | €72.16 | +0.47% | 30,60,750 |
| 14/26/14 | €71.82 | +1.53% | 32,22,320 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions


















